Moderna gets full US approval for COVID shot in at-risk children 6 months and older
Coronavirus,Coronavirus Vaccine,Vaccines,FDA
From the Center
AllSides Media Bias Rating: Center
The U.S. Food and Drug Administration has granted full approval for Moderna's (MRNA.O), opens new tab COVID-19 vaccine, Spikevax, in children aged 6 months through 11 years who are at an increased risk of the disease, the company said on Thursday.
Check for Bias
The AI-powered AllSides Bias Checker instantly reveals the bias of a news article. Tap the button to use.
Related Coverage
AllSides Picks
Red Blue Translator
Anti-vaxxer
Headline Roundup
Trump Admin Proposes Selling Federal Public Lands, Draws Bipartisan Pushback
November 18th, 2026
Headline Roundup
Hakeem Jeffries Wins Democratic Nomination for Speaker of the House
November 18th, 2026
News
Tracking Trump’s Campaign Promises
AllSides Staff
November 18th, 2026